Acromegaly: a challenging condition to diagnose
暂无分享,去创建一个
[1] C. Awoniyi,et al. Acromegaly discovered during a routine out-patient surgical procedure: a case report , 2017, Journal of Medical Case Reports.
[2] A. Tirosh,et al. Complications of acromegaly: thyroid and colon , 2017, Pituitary.
[3] S. Lamberts,et al. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future. , 2016, Endocrine-related cancer.
[4] D. Giunta,et al. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina , 2016, Archives of endocrinology and metabolism.
[5] J. Abucham,et al. Challenges in the diagnosis and management of acromegaly: a focus on comorbidities , 2016, Pituitary.
[6] V. Torri,et al. ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease , 2016, Clinical endocrinology.
[7] I. Kreitschmann-Andermahr,et al. Diagnosis and management of acromegaly: the patient’s perspective , 2016, Pituitary.
[8] K. Mukherjee,et al. Clinical profile and outcome of patients with acromegaly according to the 2014 consensus guidelines: Impact of a multi-disciplinary team. , 2015, Neurology India.
[9] P. Rosário,et al. Laboratory investigation of acromegaly: is basal or random GH > 0.4 µg/L in the presence of normal serum IGF-1 an important result? , 2015, Archives of endocrinology and metabolism.
[10] G. Baskol,et al. Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly. , 2014, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[11] F. Cordido,et al. Practical guidelines for diagnosis and treatment of acromegaly , 2013 .
[12] L. Nachtigall,et al. Acromegaly: the disease, its impact on patients, and managing the burden of long-term treatment , 2013, International journal of general medicine.
[13] A. Barkan,et al. The changing face of acromegaly—advances in diagnosis and treatment , 2012, Nature Reviews Endocrinology.
[14] F. Cordido,et al. Clinical Manifestations and Diagnosis of Acromegaly , 2012, International journal of endocrinology.
[15] S. Melmed,et al. Clinical, quality of life, and economic value of acromegaly disease control , 2011, Pituitary.
[16] D. Clemmons. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. , 2011, Clinical chemistry.
[17] Z. Karaca,et al. Micronucleus evaluation in mitogen-stimulated lymphocytes of patients with acromegaly. , 2010, Metabolism: clinical and experimental.
[18] M. Ragonese,et al. Increased prevalence of acromegaly in a highly polluted area. , 2010, European journal of endocrinology.
[19] P. Chanson,et al. A consensus on criteria for cure of acromegaly. , 2010, The Journal of clinical endocrinology and metabolism.
[20] J. Bruce,et al. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under‐recognized and under‐diagnosed , 2010, Clinical endocrinology.
[21] S. Melmed. Acromegaly pathogenesis and treatment. , 2009, The Journal of clinical investigation.
[22] Michael Buchfelder,et al. Surgical treatment of pituitary tumours. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[23] H. Wittchen,et al. High prevalence of biochemical acromegaly in primary care patients with elevated IGF‐1 levels , 2008, Clinical endocrinology.
[24] A. Barkan,et al. Current diagnosis of acromegaly , 2008, Reviews in Endocrine and Metabolic Disorders.
[25] S. Melmed. Medical progress: Acromegaly. , 2006, The New England journal of medicine.
[26] X. Matías-Guiu,et al. Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma , 2005, Journal of endocrinological investigation.
[27] G. Gamble,et al. Factors influencing mortality in acromegaly. , 2004, The Journal of clinical endocrinology and metabolism.
[28] G. Brabant. Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment. , 2003, European journal of endocrinology.
[29] H. Machado,et al. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure? , 2002, The Journal of clinical endocrinology and metabolism.
[30] L. Brunereau,et al. Cavernous sinus invasion by pituitary adenoma: MR imaging. , 2000, Radiology.
[31] M. Jeevanandam,et al. Pulsatile nature of growth hormone levels in critically ill trauma victims. , 1995, Surgery.